EP2600901A2

A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof

Abstract

This record has no abstract on file.

EP2600901A2, drawing sheet 1 — Sheet 1 of 10

Term

4.9 yearsto projected expiry

Projected expiry 5 August 2031, counted from filing; an application has no term until it is granted.

10 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10

Every citation, both ways

Citations
Document	Relation	Office	Cited during
WO2022090752A1	Cited by	World Intellectual Property Organization (WIPO)	Applicant
WO2022106860A1	Cited by	World Intellectual Property Organization (WIPO)	Applicant
CN112126616A	Cited by	China	Search report
WO2008019371A1	Cites	World Intellectual Property Organization (WIPO)	Search report
WO2008096370A2	Cites	World Intellectual Property Organization (WIPO)	Search report

18 members in 4 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
Document	Office	Kind	Date
401052P	United States of America	–	2010-08-06
40105210	United States of America	P	2010-08-06
2011046861	United States of America	W	2011-08-05

Members18

Family members, oldest first
Document	Office	Kind
CA2807552A1	Canada	A1	2012-02-09
WO2012019168A2	World Intellectual Property Organization (WIPO)	A2	2012-02-09
US2012065252A1	United States of America	A1	2012-03-15
WO2012019168A3	World Intellectual Property Organization (WIPO)	A3	2012-07-05
WO2012019168A3	World Intellectual Property Organization (WIPO)	A3	2012-07-05
EP2600901A2This record	European Patent Office (EPO)	A2	2013-06-12
EP2600901A4	European Patent Office (EPO)	A4	2014-07-16
US2014243399A1	United States of America	A1	2014-08-28
US8822663B2	United States of America	B2	2014-09-02
US9181319B2	United States of America	B2	2015-11-10
US2016024171A1	United States of America	A1	2016-01-28
US9447164B2	United States of America	B2	2016-09-20
US2017143796A1	United States of America	A1	2017-05-25
US9937233B2	United States of America	B2	2018-04-10
US2019030129A1	United States of America	A1	2019-01-31
EP2600901B1	European Patent Office (EPO)	B1	2019-03-27
EP3578205A1	European Patent Office (EPO)	A1	2019-12-11
US2022273766A1	United States of America	A1	2022-09-01

99 legal events, as 8 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2025-10-20	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2025-10-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-07-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2024-07-08	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2023-06-14	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2022-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-07-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-07-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2021-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-05-29	Lapsed because of non-payment of the annual feeLapsedMM	MM	BE
2020-05-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-05-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-05-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-05-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-03-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-03-11	No opposition filedOpposition26N	26N	EP
2020-02-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-02-07	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2020-02-07	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2020-01-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2020-01-03	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2019-12-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-12-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-11-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-11-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-09-15	Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05	MK05	AT
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-08-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-07-31	Patent invalid in the netherlands as no translation has been filedMP	MP	NL
2019-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2019-04-18	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2019-04-17	European patents granted designating irelandGrantedFG4D	FG4D	IE
2019-04-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2019-04-10	Party data changed (patent owner data changed or rights of a patent transferred)RAP2	RAP2	EP
2019-03-29	European patent takes effect as a national patent in ch/liEP	EP	CH
2019-03-27	Designated contracting statesAK	AK	EP
2019-03-27	European patent grantedGrantedFG4D	FG4D	GB
2019-02-22	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2019-02-22	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA	STAA	EP
2019-02-13	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2018-10-31	Intention to grant announcedINTG	INTG	EP
2018-10-01	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2018-10-01	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA	STAA	EP
2017-01-18	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2016-11-30	First examination report despatched17Q	17Q	EP
2016-11-11	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA	STAA	EP
2015-10-21	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-10-21	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-10-21	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-10-21	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-07-29	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-07-29	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-07-29	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-07-29	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-06-24	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2015-04-22	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2015-03-25	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-03-25	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-03-25	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2015-03-25	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2014-11-19	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2014-11-19	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2014-11-19	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2014-11-19	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2014-07-16	Supplementary search report drawn up and despatchedA4	A4	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-07-16	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2014-06-04	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2014-06-04	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2014-06-04	Information on inventor provided before grant (corrected)RIN1	RIN1	EP
2013-11-13	Request for extension of the european patent (deleted)DAX	DAX	EP
2013-06-12	Request for examination filed17P	17P	EP
2013-06-12	Designated contracting statesAK	AK	EP
2013-05-10	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof

Abstract

Term

Priority claims3

Members18

Over the term

Events

Numbers

Titles3

Classification

Designated states38